- Home
- NNOX vs ZVRA Comparison
NNOX vs ZVRA Comparison
Compare NNOX & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- ZVRA
- Stock Information
- Founded
- NNOX 2018
- ZVRA 2006
- Country
- NNOX Israel
- ZVRA United States
- Employees
- NNOX N/A
- ZVRA N/A
- Industry
- NNOX Medical Electronics
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- ZVRA Health Care
- Exchange
- NNOX Nasdaq
- ZVRA Nasdaq
- Market Cap
- NNOX N/A
- ZVRA 433.5M
- IPO Year
- NNOX 2020
- ZVRA 2015
- Fundamental
- Price
- NNOX $4.66
- ZVRA $7.65
- Analyst Decision
- NNOX Strong Buy
- ZVRA Strong Buy
- Analyst Count
- NNOX 2
- ZVRA 8
- Target Price
- NNOX $17.50
- ZVRA $22.29
- AVG Volume (30 Days)
- NNOX 1.6M
- ZVRA 519.4K
- Earning Date
- NNOX 05-27-2025
- ZVRA 03-11-2025
- Dividend Yield
- NNOX N/A
- ZVRA N/A
- EPS Growth
- NNOX N/A
- ZVRA N/A
- EPS
- NNOX N/A
- ZVRA N/A
- Revenue
- NNOX $10,680,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- NNOX $22.38
- ZVRA $281.10
- Revenue Next Year
- NNOX $153.96
- ZVRA $97.98
- P/E Ratio
- NNOX N/A
- ZVRA N/A
- Revenue Growth
- NNOX 10.79
- ZVRA N/A
- 52 Week Low
- NNOX $5.06
- ZVRA $4.20
- 52 Week High
- NNOX $11.39
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- NNOX 35.33
- ZVRA 47.41
- Support Level
- NNOX $5.70
- ZVRA $7.78
- Resistance Level
- NNOX $6.22
- ZVRA $8.33
- Average True Range (ATR)
- NNOX 0.30
- ZVRA 0.40
- MACD
- NNOX 0.01
- ZVRA -0.01
- Stochastic Oscillator
- NNOX 14.67
- ZVRA 45.30
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.